IL22 and metabolic disease: This key characteristic of state-dependent regulation—a functionality shared with IL-22 whereby potent effects are exerted in disease states with minimal homeostatic impact [33]—not only yields novel insights into the intricate control of IL-24’s biological functions but also highlights its therapeutic promise for metabolic disorders.